Tango Therapeutics, Inc. · NASDAQ:TNGX

Crystal Adam sold 27,000 Tango Therapeutics, Inc. shares (Form 4)

Traded Aug 3, 2026 · Filed Aug 5, 2026

On Aug 3, 2026, Crystal Adam (President, R&D) sold 27,000 Tango Therapeutics, Inc. shares at an average US$27.24 for US$736K under a trading plan, leaving 115,743 shares. Filed Aug 5, 2026 (Form 4).

Sold
27,000 shares
Price
US$27.24 average (US$26.79 to US$27.35)
Value
US$736K
Holding after
115,743 shares
Trading plan
Yes (Made under a plan set in advance)
Role
President, R&D

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 3, 2026Common StockOption exercise27,000US$5.20142,743Direct
Aug 3, 2026Common StockSale5,267US$26.79137,476Direct
Aug 3, 2026Common StockSale21,733US$27.35115,743Direct

Source

View original at SEC

Related